Syed Ali Aamir Rizvi is Chief Medical Officer of Caribou Biosciences, Inc.. Currently has a direct ownership of 59,373 shares of CRBU, which is worth approximately $170,994. The most recent transaction as insider was on Jan 19, 2023, when has been sold 5,627 shares (Common Stock) at a price of $6.31 per share, resulting in proceeds of $35,506. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 59.4K
0% 3M change
0% 12M change
Total Value Held $170,994

Syed Ali-aamir Rizvi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 19 2023
SELL
Open market or private sale
$35,506 $6.31 p/Share
5,627 Reduced 8.66%
59,373 Common Stock
Jan 25 2022
BUY
Grant, award, or other acquisition
-
60,000 Added 48.0%
65,000 Common Stock

Also insider at

PSTX
Poseida Therapeutics, Inc. Healthcare
SAR

Syed Ali Aamir Rizvi

Chief Medical Officer
Berkeley, CA

Track Institutional and Insider Activities on CRBU

Follow Caribou Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRBU shares.

Notify only if

Insider Trading

Get notified when an Caribou Biosciences, Inc. insider buys or sells CRBU shares.

Notify only if

News

Receive news related to Caribou Biosciences, Inc.

Track Activities on CRBU